Mirum Pharmaceuticals, Inc. — SC 13D/A Filings
15 SC 13D/A filings on record
This page lists all SC 13D/A filings submitted to the SEC by Mirum Pharmaceuticals, Inc. (MIRM), sorted by most recent first. Each row links to the full filing on EdgarLookup. Mirum Pharmaceuticals, Inc. has filed 15 SC 13D/A documents with the SEC since 2018. To view all SEC filings by Mirum Pharmaceuticals, Inc., see the full filings list.
All
10-K
10-Q
144
3
4
4/A
424B4
424B5
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
NT 10-K
S-1
S-1/A
S-3
S-3/A
S-3ASR
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SC 13D/A | NEW ENTERPRISE ASSOCIATES 16, L.P. / MIRUM PHARMACEUTICALS, INC. -- SCHEDULE 13D | 0001072613-23-000635 | Dec 29, 2023 | — |
| SC 13D/A | SC 13D/A | 0001193125-23-228444 | Sep 5, 2023 | — |
| SC 13D/A | NEW ENTERPRISE ASSOCIATES 16, L.P. / MIRUM PHARMACEUTICALS, INC. -- SCHEDULE 13D | 0001072613-23-000370 | Jun 23, 2023 | — |
| SC 13D/A | SC 13D/A | 0001193125-23-101762 | Apr 14, 2023 | — |
| SC 13D/A | SC 13D/A | 0001193125-22-296168 | Dec 1, 2022 | — |
| SC 13D/A | SC 13D/A | 0001193125-22-223931 | Aug 18, 2022 | — |
| SC 13D/A | SC 13D/A | 0001193125-22-222028 | Aug 16, 2022 | — |
| SC 13D/A | SC 13D/A | 0001193125-22-209968 | Aug 2, 2022 | — |
| SC 13D/A | SC 13D/A | 0001193125-22-100183 | Apr 8, 2022 | — |
| SC 13D/A | AMENDMENT NO 3 TO SCHEDULE 13D | 0001193125-21-255095 | Aug 24, 2021 | — |
| SC 13D/A | SC 13D/A | 0001193125-20-324514 | Dec 22, 2020 | — |
| SC 13D/A | SC 13D/A | 0001193125-20-321544 | Dec 18, 2020 | — |
| SC 13D/A | SC 13D - AMENDMENT NO. 2 | 0001193125-20-321142 | Dec 18, 2020 | — |
| SC 13D/A | SC 13D/A #1 | 0001193125-20-126318 | Apr 29, 2020 | — |
| SC 13D/A | SCHEDULE 13D - AMENDMENT NO 1 | 0001193125-20-009903 | Jan 17, 2020 | — |